APOH and Venous thrombosis: A recent systematic review and meta-analysis of the risk of thrombotic events according to aPL type indicated that the association of anti-B2GPI is greater for arterial events than for venous thrombosis in patients without systemic lupus erythematosus (SLE) [19].